Steris Company Profile

✉ Email this page to a colleague

STERIS has twenty-nine approved drugs.

There is one US patent protecting STERIS drugs.

There are two patent family members on STERIS drugs in two countries and eighty-four supplementary protection certificates in eleven countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Steriscience	FOCINVEZ	fosaprepitant dimeglumine	SOLUTION;INTRAVENOUS	216686-001	Aug 22, 2023		RX	Yes	Yes	11,065,265	⤷ Try a Trial	Y			⤷ Try a Trial
Steriscience	NAFCILLIN SODIUM	nafcillin sodium	INJECTABLE;INJECTION	200002-002	Apr 7, 2014	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Steriscience	VANCOCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	062812-002	Nov 17, 1987		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Steriscience	VANCOCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	062812-001	Nov 17, 1987		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Steriscience	VANCOCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	062812-003	Nov 17, 1987		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
China	112243376	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2019221815	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1948158	93075	Luxembourg	⤷ Try a Trial	PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN, C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3'-METHYL-2-(PENTANYOL(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE) DE TRISODIUM HEMIPENTAHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123
1758590	LUC00029	Luxembourg	⤷ Try a Trial	PRODUCT NAME: SEL DE SODIUM D'ACIDE DEOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: IS/1/16/071/01 20170401
1856135	2020/017	Ireland	⤷ Try a Trial	PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REGISTRATION NO/DATE: EU/1/19/1405 20200113
1259550	08C0052	France	⤷ Try a Trial	PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
2666774	CR 2020 00037	Denmark	⤷ Try a Trial	PRODUCT NAME: RELEBACTAM, OPTIONALLY IN THE FORM OF THE MONOHYDRATE, IMIPENEM AND CILASTATIN, OPTIONALLY IN THE FORM OF THE SODIUM SALT; REG. NO/DATE: EU/1/19/1420 20200217
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.